Jazz Pharmaceuticals plc buy Barclays PLC
Start price
29.01.24
/
50%
€116.60
Target price
29.01.25
€217.33
Performance (%)
-14.53%
Price
04.10.24
€99.66
Summary
This prediction is currently active. The price of Jazz Pharmaceuticals plc has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.53%. This prediction currently runs until 29.01.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Jazz Pharmaceuticals plc | 1.178% | 1.178% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Barclays_PLC for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target lowered by analysts at Barclays PLC from $240.00 to $235.00. They now have an "overweight" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Barclays_PLC for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€102.25
03.05.24
03.05.24
€185.60
03.05.25
03.05.25
-2.53%
04.10.24
04.10.24
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€109.55
01.03.24
01.03.24
€212.20
01.03.25
01.03.25
-9.03%
04.10.24
04.10.24